UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000061599
Receipt number R000070479
Scientific Title Development of an FIM Prediction Model for Stroke Patients in Convalescent Rehabilitation Wards Considering the Impact of Aging
Date of disclosure of the study information 2026/05/31
Last modified on 2026/05/17 06:11:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of an AI Model to Predict Functional Recovery after Stroke Rehabilitation

Acronym

stroke AI-based Rehabilitation prognosis prediction with Advanced Interpretability

Scientific Title

Development of an FIM Prediction Model for Stroke Patients in Convalescent Rehabilitation Wards Considering the Impact of Aging

Scientific Title:Acronym

Aging-aware Gradient Estimation of FIM in stroke rehabilitation

Region

Japan


Condition

Condition

stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To develop a Random Forest model predicting discharge FIM scores in stroke patients in convalescent rehabilitation wards, incorporating aging-related variables, and to evaluate its predictive accuracy and clinical interpretability using SHAP analysis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Discharge motor FIM total score

Key secondary outcomes

- Discharge total FIM score - Discharge cognitive FIM total score- Individual FIM sub-item scores- Model performance - Variable contribution via SHAP values- Age-stratified model performance


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients admitted to the convalescent rehabilitation ward at Shin-Sapporo Neurosurgical Hospital between January 2018 and March 2020
Patients with a primary diagnosis of cerebral infarction or intracerebral hemorrhage
Patients with a length of stay in the convalescent rehabilitation ward of at least one month

Key exclusion criteria

Patients with a history of neurological diseases (e.g., Parkinson's disease, multiple sclerosis)
Patients with a history of psychiatric disorders (e.g., schizophrenia, bipolar disorder)
Patients with a history or complication of brain tumor
Patients who experienced clinical deterioration during hospitalization (e.g., stroke recurrence, pneumonia, exacerbation of heart failure)
Patients with blindness
Patients who developed stroke during hospitalization at another medical facility
Patients with missing data

Target sample size

300


Research contact person

Name of lead principal investigator

1st name ryo
Middle name
Last name matsuda

Organization

Hokkaido University of Science

Division name

department of Physical Therapy Faculty of Health Sciences

Zip code

0068585

Address

4-1, 15-chome, Maeda 7-jo, Teine-ku, Sapporo, Hokkaido 006-8585, Japan

TEL

0116887197

Email

matsuda-r@hus.ac.jp


Public contact

Name of contact person

1st name ryo
Middle name
Last name matsuda

Organization

Hokkaido University of Science

Division name

department of Physical Therapy Faculty of Health Sciences

Zip code

0068585

Address

4-1, 15-chome, Maeda 7-jo, Teine-ku, Sapporo, Hokkaido 006-8585, Japan

TEL

0116887197

Homepage URL


Email

matsuda-r@hus.ac.jp


Sponsor or person

Institute

Hokkaido University of Science

Institute

Department

Personal name

Ryo Matsuda


Funding Source

Organization

Hokkaido University of Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Rehabilitation, Neuroscience Research Center Shin Sapporo Neurosurgical Hospital

Address

2-10, 6-chome, Atsubetsu-chuo 1-jo, Atsubetsu-ku, Sapporo, Hokkaido 004-0051, Japan

Tel

0118912500

Email

pt@snh.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

304

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 03 Month 07 Day

Date of IRB

2022 Year 03 Month 07 Day

Anticipated trial start date

2022 Year 03 Month 07 Day

Last follow-up date

2026 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study was approved by the Ethics Committee of the Graduate School of Health Sciences, Hirosaki University (approval number: 2025-008, approval date: August 18 , 2025) and the Institutional Review Board of Shin-Sapporo Neurosurgical Hospital (approval date: March 7, 2022) as a retrospective observational study using existing clinical data. Individual informed consent was waived, and study information is disclosed on the hospital's notice board and website (opt-out approach). All data will be anonymized prior to analysis.


Management information

Registered date

2026 Year 05 Month 17 Day

Last modified on

2026 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070479